Literature DB >> 7763123

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.

D Pittet1, R P Wenzel.   

Abstract

BACKGROUND: Nosocomial bloodstream infections occur at a rate of 1.3 to 14.5 per 1000 hospital admissions and are believed to lead directly to 62,500 deaths per year in the United States. Measures of the incidence and the proportion of all hospital deaths related to deaths from these infections provide estimates of their impact. The objectives of the study were to characterize the secular trends in nosocomial bloodstream infection at a single institution and to estimate the population-attributable risk for death among patients experiencing the infection.
METHODS: A 12-year retrospective study using prospectively collected data from a hospital-wide surveillance system for nosocomial infections in a 900-bed tertiary care institution. All patients (N = 260,834) admitted to the institution between 1980 and 1992 were included in the study. Bloodstream infection rates were calculated for the 10 leading groups of pathogens, and trends were analyzed using simple linear regression. In-hospital mortality rates from patients who did or did not develop nosocomial blood stream infections were compared.
RESULTS: Between 1980 and 1992, a total of 3077 patients developed 3464 episodes of nosocomial bloodstream infection. The crude infection rates increased linearly from 6.7 to 18.4 per 1000 discharges (0.83 to 1.72 episodes per 1000 patient-days) during the 12-year study period (r = .87). Increases in the infection rates were due to gram-positive cocci (r = .96) and yeasts (r = .95) and essentially explained by infections caused by coagulase-negative staphylococci, Staphylococcus aureus, enterococci, and Candida species, respectively. Although the crude mortality in patients with nosocomial bloodstream infections decreased from 51% in 1981 to 29% in 1992, the in-hospital population-attributable mortality among infected patients increased from 3.55 deaths per 1000 discharges in 1981 to 6.22 per 1000 discharges in 1992 (r = .67). The etiologic fraction or the proportion of deaths in patients with bloodstream infection to all deaths occurring in the hospital increased from 11.4% in 1981 to 20.4% in 1992 (r = .59).
CONCLUSIONS: The incidence, the etiologic fraction, and the population-attributable risk for death among patients experiencing nosocomial bloodstream infections increased progressively during the last decade.

Entities:  

Mesh:

Year:  1995        PMID: 7763123     DOI: 10.1001/archinte.155.11.1177

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  88 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

Authors:  Toshiro Mizuno; Noriyuki Katsumata; Hirofumi Mukai; Chikako Shimizu; Masashi Ando; Toru Watanabe
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

4.  Secreted aspartate proteinases, a virulence factor of Candida spp.: occurrence among clinical isolates.

Authors:  P Hamal; J Dostál; V Raclavský; M Krylová; I Pichová; O Hrusková-Heidlngsfeldová
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Direct identification of major blood culture pathogens, including Pseudomonas aeruginosa and Escherichia coli, by a panel of fluorescence in situ hybridization assays using peptide nucleic acid probes.

Authors:  M Søgaard; H Stender; H C Schønheyder
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

6.  What do central venous catheter-associated bloodstream infections have to do with bundles?g.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

7.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

8.  Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay.

Authors:  Younes Maaroufi; Corine Heymans; Jean-Marc De Bruyne; Valerie Duchateau; Hector Rodriguez-Villalobos; Michel Aoun; Françoise Crokaert
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Risk factors for bloodstream infections at a cancer center.

Authors:  E Velasco; L C Thuler; C A Martins; L M Dias; V M Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

10.  A 7-year study of bloodstream infections in an English children's hospital.

Authors:  James W Gray
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.